MMA
LABD icon

Miracle Mile Advisors’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Miracle Mile Advisors’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-98
Closed -$359K – 274
2019
Q1 		$359K Buy
98
+67
+216% +$325K 0.03% 205
2018
Q4 		$265K Buy
+31
New +$227K 0.03% 118

Other funds holding LABD

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Miracle Mile Advisors's LABD Position: Q2 2019 in Review

Miracle Mile Advisors sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q2 2019, closing a stake of 98 shares — an estimated $359K sold.

Miracle Mile Advisors first reported a position in LABD in Q4 2018 and held it in 2 quarters. The position peaked at $359K in Q1 2019. 11 funds tracked by Wall St. Rank hold LABD as of Q2 2019.

  • Miracle Mile Advisors reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q2 2019 after selling out during the quarter.
  • Miracle Mile Advisors sold 98 Direxion Daily S&P Biotech Bear 3X ETF shares in Q2 2019, an estimated $359K.
  • Miracle Mile Advisors first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q4 2018 and held it in 2 quarters.
  • Miracle Mile Advisors's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $359K in Q1 2019.
  • 11 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2019.

Based on Miracle Mile Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.